Introduction

I
schemic cardiomyopathy is caused by insufficient blood supply to the heart, which can lead to significant cardiomyocyte death and subsequent loss of heart function and heart failure. 1 This process is essentially irreversible as the regenerative capacity of the heart is limited with an estimated cardiomyocyte renewal rate of only 1-2% per year in adult humans. 2 Furthermore, while conventional therapies for heart failure mitigate symptoms and modestly prolong life, they are palliative as they do not resolve the fundamental loss of functional cardiac tissue. 3 Cardiac tissue engineering has emerged as a potential method to reconstruct the structure and function of injured myocardial tissue. 4 Three-dimensional (3D) cardiac tissue models have significantly progressed, but are still restricted in their size and thickness due to limited diffusion of nutrients.
of a complex vascular network that transports oxygen and nutrients to tissues, therefore vascularization strategies of engineered cardiac tissues have become a top priority. 6, 7 Current cardiac tissue engineering attempts have included the use of a wide variety of biomaterials such as synthetic and natural bioactive hydrogels, peptides with cell adhesionsupporting capacity, 8 degradable polymer scaffolds, 9 and bioink deposition technologies. 7, 10 However, incorporation of foreign biomaterial poses the concern for significant inflammation and host response after implantation. [11] [12] [13] In our study, we optimized a hanging drop method to create cell spheroids comprising human induced pluripotent stem cellderived cardiomyocytes (hiPSC-CMs), human cardiac fibroblasts (HCFs), and human umbilical vein endothelial cells (HUVECs). We then utilized these spheroids in a simple and novel net mold method to create a biomaterial-free cardiac tissue of predetermined size and shape. We compared the net mold patches against gel patches in which the same spheroids were seeded into collagen gels. We hypothesized that our biomaterial-free net mold patches would exhibit increased cellular alignment, electrical integration, and less central necrosis compared with gel patches.
Materials and Methods
Experimental protocol overview
A schematic representation of the experimental protocol is shown in Figure 1 . hiPSC-CMs, HCFs, and HUVECs were suspended in a predetermine ratio and dispensed into a hanging drop device to create cell spheroids. The spheroids were then collected and seeded into the mold cavity. After culture for a period of days, the spheroids fused into a multilayered tissue, resulting in a cardiac patch after decannulation from the mold.
Generation of hiPSC-CMs hiPSCs were kindly provided by G. Tomaselli and D. DiSilvestre and used in accordance with university IRB regulations. Before establishment of this hiPSC line, consent had been obtained from the Caucasian female donor. All methods described were carried out in accordance with Johns Hopkins University regulations and guidelines and approved by the university IRB. No human subjects were included in the study. Differentiation into cardiomyocytes was performed by temporal modulation of the Wnt signaling pathway using small molecules (CHIR99021, Tocris; R&D Systems, cat. no. 4423, and IWR-1; Sigma-Aldrich, cat. no. I0161) as previously described.
14 hiPSC-CMs were utilized between days 16 and 18 after differentiation only if beating was verified by light microscopy on gross examination.
Spheroid creation by the hanging drop device hiPSC-CMs, HCFs, and HUVECs were trypsinized and resuspended in the corresponding media. hiPSC-CMs,
FIG. 1.
A schematic representation of our experimental protocol. A cell suspension containing three cell types (hiPSC-CMs, HCFs, and HUVECs) was dispensed into hanging drop devices to create cardiac spheroids. First, the filling base and net mold were rinsed with 1 · phosphatebuffered saline and placed on the handling mat. Then, the spheroids were collected and seeded into the net mold cavity. The net mold consisted of holding tubes, stoppers, square plates, and top/bottom nets. After several days of culture on a shaker in the incubator, a multilayered cardiac patch results after removal from the mold. HCFs, human cardiac fibroblasts; hiPSC-CMs, human induced pluripotent stem cell-derived cardiomyocytes; HUVECs, human umbilical vein endothelial cells. HCFs, and HUVECS were then combined in a ratio of CMs:HCFs:HUVECs = 70:15:15. The mixed cell suspension was then dispensed into hanging drop devices (ElplasiaÔMpc 350; Kuraray Co., Ltd., Tokyo, Japan) and allowed to coculture in Roswell Park Memorial Institute (RPMI) cell media supplemented with B-27 (RPMI/B-27 cell media). A total of 4 mL of media was contained in each hanging drop device. The hanging drops were cultured at 37°C, 5% carbon dioxide, and 95% humidity for 72 h to allow formation of cell spheroids. After 72 h, spheroids were collected from the hanging drop device and used for tissue creation.
Creation of net mold patches
Cell spheroids were harvested after 72 h of culture in the hanging drop device. The spheroids were then seeded into the net mold (NM25-1; TissueByNet, Tokyo, Japan) cavity of presupposed size. The net mold comprised a plastic base and square stainless steel plate, bottom net, 10 layers of side nets, top net, and top square plate. The side nets are layered in alternating directions to create cavities (Fig. 1) . The spheroids are filled into the cavities, as described previously. 15 Briefly, the filling base is placed on the handling mat and wetted with 1 · phosphate-buffered saline (PBS). The net mold is then placed over the filling base and spheroids are seeded into the desired cavity. The top net and top square plate are then placed onto corner posts to seal the mold, and then the entire net mold device is transferred to a six-well plate with RPMI media supplemented with B-27 for culture on a shaker in an incubator at 37°C, 5% carbon dioxide, and 95% humidity. Total culture time was dependent on the patch size and was, on average, between 7 and 10 days. The resultant cardiac patch was then obtained after decannulation of tissue from the mold system. The patches were then cultured in free-floating media for a period of time to achieve the desired total culture time before evaluation.
Creation of gel patches using collagen A collagen stock solution was prepared before use by mixing sterile 10 · PBS, sterile distilled water (dH 2 O), sterile 1 N NaOH, and 3 mg/mL collagen I rat tail (A10483-01; Life Technologies Corporation, Carlsbad, CA) to achieve a final concentration of 2 mg collagen/mL, 4°C, as specified by the manufacturer. This stock solution was then mixed with an equal volume of RPMI/B-27 cell media with spheroids to create a gel with 1200 spheroids. The gel patch was allowed to polymerize for 30 min in the incubator before addition of 1 mL of RPMI/B-27 cell media on top of the gel patch. Gels were incubated at 37°C, 5% carbon dioxide, and 95% humidity, and the medium was changed every day. The gel patches were cultured until the desired total culture time before final evaluation and assessment.
Immunohistochemistry
Cardiac tissues were fixed with 10% formalin before embedding in paraffin. Resultant tissue sections (5 mm) were deparaffinized and stained with hematoxylin-eosin (H&E) and Masson, as previously described. 16 Net mold and gel patches were fixed in 4% paraformaldehyde, embedded in O.C.T. compound (Tissue-PlusÔ; Thermo Fisher, Waltham, MA), and cut into 8-mm sections. The sections were then washed once for 5 min in 1 · PBS, incubated in 0.2% Triton X for 5 min, washed three times for 5 min in 1 · PBS, and subsequently blocked for 1 h using 10% goat serum. Sections were then incubated with primary antibodies overnight; primary antibodies utilized included troponin T (1:200 dilution; Abcam, ab 45932), sarcomeric alpha-actinin (1:200 dilution; Abcam, ab137346), connexin 43 (1:50 dilution; Millipore, MAB 3067), CD31 (1:50 dilution; Thermo Scientific, RB10333-P), and collagen I (1:200 dilution; Abcam, ab7778). Sections were washed three times for 5 min in 1 · PBS followed by incubation with the appropriate secondary antibody for 1 h at room temperature. Sections were then washed three times for 5 min with 1 · PBS before mounting using Vectashield antifade mounting medium with 4¢,6-diamidino-2-phenylindole (DAPI) (Vector Laboratories, Burlingame, CA). Collagen expression was evaluated by measuring fluorescence intensity under the same light source intensity. Quantification and cell counts were performed using ImageJ software on representative images for each sample.
Cell viability analysis
Cell viability was assessed using a TUNEL assay (DeadEndÔ Fluorometric TUNEL System; Promega, Madison, WI). Tissue sections for both the net mold patches and gel patches were stained using the kit, as directed by the manufacturer. Live and dead cells were counted using ImageJ software on representative images of the periphery (n = 6) and center (n = 6) of samples.
Exosome isolation and analysis
Extracellular vesicles (EVs) were isolated as previously described. 17 Briefly, patches were incubated in RPMI media for indicated time periods, supernatant was collected, and EVs were isolated through differential centrifugation. EV concentration was assessed by NanoTracking Analysis software following imaging with a NanoSight LM10, as described previously. 18 Samples were analyzed with 60-s exposure at camera level 16 and threshold level 8.
In vivo implantation on hearts
All animal procedures described were reviewed and approved by the Johns Hopkins University Animal Care and Use Committee (ACUC) and performed in accordance with federal guidelines for the care and use of laboratory animals. The protocol number was RA16M150. Female nude Lewis rats aged 8-10 weeks were anesthetized using inhaled 2% isofluorane, intubated, and placed on ventilatory support for the duration of the procedure. The heart was exposed through median sternotomy, and the left anterior descending artery (LAD) was identified. An 8-0 Prolene suture (Ethicon, Inc., Johnson and Johnson, Somerville, NJ) was placed and tied in the anterior myocardium to occlude the LAD. Myocardial infarction was visually confirmed by observation of myocardial blanching. Immediately after occlusion, the cardiac patch of interest was secured over the free wall of the left ventricle with Tisseel fibrin sealant (cat. no. 1504516). Animals in the control acute myocardial infarction (AMI) group underwent all surgical procedures for myocardial infarction except for implantation of the patch. Hemostasis was achieved and the sternal incision was closed with 7-0 Prolene sutures; the skin was closed with 4-0 Prolene sutures. The rat was then weaned from the ventilator and extubated. Standard postoperative care, including analgesia, was administered until the animals ate normally and became active.
Animals were sacrificed 4 weeks after implantation. The left ventricular (LV) free wall was cut horizontally into three rings (R1-R3), each ring was sequentially cut into two samples that were processed, embedded, and sectioned into 5-mm sections for histology. Vascular density was evaluated by counting the number of vascular structures that were positive for CD31 expression. Infarct size was measured as previously described 19 using stained samples with Masson's trichrome staining and presented as the ratio of scar surface area to the total LV surface area. performed in conscious rats 4 weeks after surgery. The animals were held in a supine position. The heart was imaged in two-dimensional mode in the parasternal short-axis view. An M-mode pointer was positioned perpendicular to the interventricular septum and the LV posterior wall at the level of papillary muscles. The following measurements were assessed: left ventricular internal diameter at enddiastole and end-systole (LVID; s/d), interventricular septal thickness at end-diastole (IVS; d), left ventricular posterior wall thickness at end-diastole (LVPD; d), and LV mass. High-frame rate color Doppler imaging was performed three times for each rat from a frozen M-mode tracing. Ejection fraction (EF) and LVID; s/d were calculated from these parameters.
Statistics
For all experiments, data are represented graphically as bar or line charts with error bars, representing the mean with standard error of the mean. Statistical comparisons were performed by one-way analysis of variance (ANOVA) for the different groups, followed by post hoc pairwise repetitive comparisons using Tukey's test with OriginLab 9.0 data analysis and graphing software. Statistical significance was considered at p < 0.05. 5 cells/mL, and 24.75 · 10 5 cells/mL) were evaluated over time. As the concentration of the cell suspension increased, the diameter of spheroids was also observed to significantly increase ( Fig. 2A, C) . The concentration of 24.75 · 10 5 cells/mL was chosen as the optimal cell concentration to maximize spheroid size in the hanging drop device. Spheroid diameter was observed to plateau after 12 h of culture (Fig. 2B, D) , and the beating rate of spheroids was observed to increase exponentially over the course of 72 h of culture before seeding into the mold (Fig. 2E) .
Results
Optimization of
spheroid size using the hanging drop device Each hanging drop device utilized contained 850 micropores, each with a diameter of 350 mm. To optimize the size of cardiospheres formed from hanging drop devices, three varying cell concentrations (8.25 · 10 5 cells/mL, 16.5 · 10
Morphology of net mold-based cardiac patch
After decannulation from the mold, the net mold patch was found to have a solid, opaque square shape both without magnification and under 4 · magnification (Fig. 3A, B) . The net mold patch was observed to have coordinated and consistent contraction, suggesting mechanical and electrical integration of spheroids. Staining for cell nuclei revealed that the net mold patch had a thickness of 739 -74 mm (Fig. 3E, F) . Furthermore, staining with H&E revealed that the spheroids had successfully fused in the net mold patch with formation of an intrinsic extracellular matrix (Fig. 3I ).
Histological analysis of net mold cardiac patches
Immunohistochemistry confirmed that the net mold patches comprised cardiomyocytes expressing sarcomeric alpha-actinin (Fig. 3C ) and troponin T (Fig. 3D) , with alignment of cardiomyocytes observed on confocal microscopy. Additionally, connexin 43 expression was observed throughout the patch (Fig. 3G) , suggesting electrical integration of cardiomyocytes. Primitive vascularization of the patch was observed with several areas of CD31-positive cells noted throughout the patch (Fig. 3H) , and significant survival of the entirety of the patch was confirmed with TUNEL staining, which demonstrated a mean cell viability of 95.6% after 1 week of culture following removal from the net mold (Fig. 3J) .
Immunohistochemical analysis of the net mold patch compared with the gel patch revealed that the net mold patch had significantly higher density of cells and positive expression of troponin T and sarcomeric alpha-actinin in both the center and periphery of the patch compared with the gel patch (Fig. 4A ). Interestingly enough, for both the net mold patch and gel patch, the majority of cells were concentrated at the periphery of patches compared with the center. The cardiomyocytes at the periphery also exhibited increased sarcomere length and cell length in the net mold patch compared with the gel patch (Fig. 4C, D) .
Furthermore, primitive vascularization of the patch measured by the number of CD31-positive cells was found to be significantly higher in the net mold patch compared with the gel patch in both the center and border of the patches (Fig. 4B,  E) . Structural integrity of the patch was also assessed by examining expression of collagen I at 4 weeks. The net mold patch was found to have significantly more collagen I expression compared with the gel patch after 4 weeks of culture, both at the center of the patch and at the border (Fig. 5A, B) .
Exosome analysis of net mold cardiac patches
Protein secretion per EV was noted to be higher in net mold patches compared with a cell suspension of single cardiomyocytes, suggesting a potential mechanism for paracrine effects (Fig. 5C ).
Echocardiography after patch implantation in an LAD ligation model
Cardiac function was evaluated 4 weeks after surgical implantation of patches using transthoracic echocardiography. LVEF was significantly higher in the net mold patch group (78.37% -5.86%) compared with the AMI group (58.43% -14.85%) and gel patch group (69.46% -16.79%) (Fig. 6A) . Left end-diastolic diameter (LVIDd) and left endsystolic diameter (LVIDs) were both significantly smaller in the gel patch and net mold patch groups compared with the AMI control group (Fig. 6B, C) .
Histological analysis of explanted cardiac tissue
The scar areas of infarction were quantified as a percentage of the total LV surface area from Masson's trichrome staining (Fig. 7A) . The scar area in the net mold patch group was smaller than in the gel patch and AMI groups (19.97% - LVIDd and (C) LVIDs in AMI, GP, and NP groups. The EF in the NP group was significantly higher compared to the control AMI group and implantation of the GP. n = 4 in each group (*p < 0.05; # p < 0.05) for comparison between the GP and NP groups. AMI, acute myocardial infarction; LVEF, left ventricular ejection fraction; LAD, left anterior descending artery; LVIDd, left ventricular internal diameter at end-diastole; LVIDs, left ventricular internal diameter at end-systole.
3.35% compared with 22.00% -8.45% and 22.42% -10.68%, respectively) (Fig. 7A, C) . Revascularization of infarcted areas was also evaluated by staining for CD31-positive endothelial cells (Fig. 7B) . Infarcted areas in the net mold patch group had significantly increased number of endothelial cells (38.50 -2.05 cells/hpf) compared with infarcted areas in the gel patch and AMI groups (26.8 -2.09 and 28.7 -2.57 cells/ hpf, respectively) (Fig. 7D) .
Discussion
This study successfully optimized and demonstrated the use of a novel net mold system to create biomaterial-free cardiac tissues. Current cardiac tissue engineering efforts strive to create tissue grafts that can augment and replace an ischemic or diseased myocardium. However, existing techniques are either reliant on scaffolding material or limited in scale due to lack of vascularization. Many other studies have created tissues using collagen as a scaffolding material, either by seeding collagen gels or incorporating collagen during formation of the tissue, which is why we chose to compare our biomaterial-free patches against collagenbased gel patches. Our use of the net mold system allows us to create biomaterial-free viable tissues that are thicker than previous studies [20] [21] [22] [23] [24] [25] [26] [27] and are able to augment function in an in vivo LAD ligation model.
The biomaterial-free cardiac tissue grafts created by the net mold were found to exhibit increased cell concentration, increased sarcomere length, and increased cell length when compared with collagen gel patches. Interestingly, the majority of cells were grouped at the borders of the patch compared with the center despite demonstrated viability throughout the patch. These findings may be related to the culture of the tissue in the net mold on a rotational shaker during tissue fusion as the edges of the tissue graft are exposed to mechanical stimulation from the mold surfaces compared with cells at the center of the patches.
The finding of improved maturation in the net mold patches compared with gel patches supports the echocardiography findings when tissue grafts were used in an in vivo LAD ligation model. The most direct correlation was a significantly increased EF in rats in which the net mold patch was implanted after LAD ligation compared with AMI alone and implantation of the gel patch. Our studies found improved cardiac function in rats in which a tissue graft was implanted, with the most improvement in cardiac function observed in the net mold patch group. As expected, the LVIDd was significantly increased in the AMI group compared with the gel and net mold patch groups as the diseased myocardium is unable to eject blood as efficiently, resulting in a more dilated LV cavity at the end of diastole. Functional augmentation was exhibited in both gel patch and net mold patch groups, with implantation of net mold patches resulting in the greatest preserved EF. One possible explanation for this improved functional benefit is increased paracrine activity from the implanted net mold patches. For example, higher protein content per EV was observed for net mold patches compared with an equivalent number of cardiomyocytes in suspension. Another possibility is that the net mold patches may have improved electrical conduction compared with gel patches. Initial analyses in net mold patches evaluated at 1, 2, and 4 weeks of in vitro culture revealed coordinated electrical conductivity with optical mapping. Furthermore, conduction velocity was found to be higher in a net mold patch compared with a gel patch after 4 weeks of in vitro culture (Supplementary Fig. S1 ). We acknowledge that the augmented function is likely secondary to the paracrine effect of the tissue graft rather than mechanical augmentation.
Despite advances made with engineered cardiac tissues, the size and thickness of current engineered tissues have been severely limited by the lack of a vascular system. To balance the goals of creating a thicker cardiac tissue and avoiding a necrotic core, many novel approaches have been investigated. Sakaguchi et al. combined a sandwiching technique for oriented cell sheets with the use of vascular bed bioreactors to form an endothelial network and overcome the issue of a necrotic core. 24 Pimentel et al. presented a method for fabrication of thick and densely populated tissue constructs with the utilization of a perfusion system for extended time periods (>14 days). 28 Riemenschneider et al. demonstrated that tissue patches containing a high density of either aligned or randomly oriented, human preformed microvessels resulted in more rapid perfusion when utilized in a myocardial infarct model. 29 In our net mold system, use of the mold cavity removes the need to utilize biomaterials for tissue fusion, allowing perfusion of nutrients and oxygen to deeper portions of the tissue during formation and preventing the formation of a necrotic core. Both the TUNEL staining we performed and quantification of CD31-positive cells support the concept of early vascularization in the net mold patch allowing for improved viability despite creation of a thicker tissue.
Looking toward scaling these processes to create clinically applicable grafts, the net mold method is a system that is adaptable and amenable to variation in size, thickness, and shape of the tissue created. Furthermore, the system does not require any advanced skills or techniques, allowing for use of the system by a wide range of operators. While the presented study findings are promising, we recognize that our study is limited as it has only explored hiPSC-CMs, we have not examined other tissue graft sizes, and we have not evaluated the net mold patch against other types of biomaterial-based tissues.
Our findings demonstrate that biomaterial-free cardiac tissues created using a novel net mold method are superior in augmenting function and neovascularization after implantation onto rodent hearts in an LAD ligation model compared with no-tissue graft implantation and implantation of a collagen-based gel patch. We found that biomaterialfree tissue grafts exhibited improved maturation, viability, and vascularization when compared with biomaterial-based gel patches, suggesting a benefit in pursing biomaterial-free tissue grafts in the future. The results presented demonstrate significant progress toward development of clinically applicable tissue grafts by creating biomaterial-free human cardiac tissues utilizing only hiPSC-CMs, HCFs, and HUVECs. Further work will be required to improve maturation and vascularization of these tissue grafts to create tissues on a clinically applicable scale.
